Tag: Menopause / Postmenopause
Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Women with persistently high VMS have increased risk for diabetes versus those with persistently low VMS
ACG: Hormone Therapy Tied to Higher Risk for New Irritable Bowel Syndrome
Hormone replacement therapy also tied to elevated gastrointestinal symptoms and diagnostic testing
Lower Risk for Asthma Seen With Younger Age at Natural Menopause
Hazard ratio of 0.70 reported for risk for asthma with age at natural menopause of 40 to 44 versus 50 to 54 years
Primary Care EHRs Fail to Capture Extent of Menopause Symptoms
Additionally, vasomotor symptoms remain undertreated
Premature Ovarian Insufficiency Linked to Autoimmune Diseases
Women diagnosed with POI have increased prevalence of several specific autoimmune diseases
1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
Decreases seen for women aged younger than 52 years, 52 to <65 years, and 65 years and older, and for Hispanic, non-Hispanic Black, non-Hispanic White women
Gestational Hypertension Tied to Higher Later Risk for Cardiovascular Disease
No associations seen for preeclampsia or eclampsia or gestational diabetes
Hot Flashes May Occur More Often in Second Half of Nightly Sleep
Authors say future research needed to see impact on REM sleep, cardiovascular disease
Review Weighs Treatments for Genitourinary Symptoms of Menopause
Vaginal estrogen, vaginal DHEA, oral ospemifene, vaginal moisturizers may be beneficial for some genitourinary symptoms
2007 to 2023 Saw Decline in Menopausal Hormone Therapy Usage Rates
Rates declined and remained low for women aged 45 to 49, 50 to 54, and 55 to 59 years
